AI-DRIVEN MICROBIOME-BASED BIOMARKERS FOR EARLY DIAGNOSIS OF CANCER AND AUTOIMMUNE DISEASES: CURRENT ADVANCES AND FUTURE PERSPECTIVES. rjnmsr. 2026;4(3):822-832. doi:10.63075/s7xxds32